Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Respirology Case Reports|August 12, 2024
Diffuse large B-cell lymphoma presenting with pulmonary artery compression symptoms, case reportsMhd Baraa Habib, Khaled Ali, Mohamad Fael, et al.
Journal of Blood Medicine|November 9, 2023
Glanzmann Thrombasthenia Associated with Siderotic Synovitis and Arthropathy: A Case ReportMouhammad J Alawad, Mohammad Abu-Tineh, Awni Alshurafa, et al.
European Journal of Haematology|April 13, 2026
Anemia of Chronic Disease Revisited: Hepcidin Dysregulation, Erythropoietic Failure, and Emerging Roles of SGLT2 InhibitionMohammed Abdulgayoom, Awni Alshurafa, Rasha Kaddoura, et al.
Cureus|January 6, 2021
Bilateral Foot-Drop Secondary to Axonal Neuropathy in a Tuberculosis Patient With Co-Infection of COVID-19: A Case ReportMohammad H AlKhateeb, Afia Aziz, Mugahid Eltahir, et al.
Hematology (Amsterdam, Netherlands)|November 11, 2024
Successful eradication of acquired factor VIII inhibitors with rituximab: a report of two casesMain Atallah Mohammed Abumahfouz, Anas Al-Sadi, Awni Alshurafa, et al.
Oncology|June 8, 2026
Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational StudyAwni Alshurafa, Mohammed Abdulgayoom, Rola Ghasoub, et al.
Cureus|March 20, 2023
A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation DilemmaAhmed K Yasin, Mohammad Abu-Tineh, Awni Alshurafa, et al.
Cureus|June 24, 2022
A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute LeukemiaElrazi A Ali, Mohammed A Alamin, Mohammad Abu-Tineh, et al.
Oncology|March 30, 2026
Impact of Tyrosine Kinase Inhibitors on Estimated Glomerular Filtration Rate in Chronic Myeloid Leukemia PatientsAwni Alshurafa, Maria Benkhadra, Nabeel Mohammad Qasem, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2023
Recurrence of acute chest syndrome post stopping Crizanlizumab, the dilemma of stopping vs continuation in patient with sickle cell disease: case reportMohammad S Afana, Mohammad Abu-Tineh, Awni Alshurafa, et al.
Pageof 11